Jan Keltjens has resigned as president and CEO of interventional technology developer AngioDynamics, effective immediately.
A search for his replacement is under way. In the meantime, Scott Solano, senior vice president and chief technology officer, will serve as interim CEO, according to the vendor.
In other company news, the firm said that it expects to post fourth-quarter net sales of approximately $56.4 million, down from the $60.3 million booked in the fourth quarter of 2010. Final results will be released on July 14.
